Article thumbnail

Radiotherapy Suppresses Angiogenesis in Mice through TGF-βRI/ALK5-Dependent Inhibition of Endothelial Cell Sprouting

By Natsuko Imaizumi, Yan Monnier, Monika Hegi, René-Olivier Mirimanoff and Curzio Rüegg
Topics: Research Article
Publisher: Public Library of Science
OAI identifier: oai:pubmedcentral.nih.gov:2884035
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (2003). A
  2. (1992). A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor.
  3. (2004). A study on the activity of fibroblast cells in connection with tissue recovery in the wounds of skin injury after wholebody irradiation.
  4. (2006). A systems biology approach to multicellular and multi-generational radiation responses.
  5. (2002). Activated Notch4 inhibits angiogenesis: role of beta 1-integrin activation.
  6. (2004). Akt negatively regulates the in vitro lifespan of human endothelial cells via a p53/ p21-dependent pathway.
  7. (2004). Angiogenesis and signal transduction in endothelial cells.
  8. (2009). Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis.
  9. (2006). Apoptosis is initiated in human keratinocytes exposed to signalling factors from microbeam irradiated cells.
  10. (2002). Balancing the activation state of the endothelium via two distinct TGF-beta type I receptors.
  11. (1997). Coactivation of AP-1 activity and TGF-beta1 gene expression in the stress response of normal skin cells to ionizing radiation.
  12. (2007). Critical role of endothelial Notch1 signaling in postnatal angiogenesis.
  13. (2008). CYR61 and alphaVbeta5 integrin cooperate to promote invasion and metastasis of tumors growing in preirradiated stroma.
  14. El-Deiry WS (2003) P53 and radiation responses.
  15. (1998). Evidence for the involvement of endothelial cell integrin alphaVbeta3 in the disruption of the tumor vasculature induced by TNF and IFN-gamma.
  16. (1995). Expression of transforming growth factor-beta 1 in mouse skin during the acute phase of radiation damage.
  17. (1984). Failure at distant sites following multimodality treatment for advanced head and neck cancer.
  18. (2000). Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials.
  19. (2008). Genistein induces radioprotection by hematopoietic stem cell quiescence.
  20. (2004). Giaccia A
  21. (2008). Gurbuz A
  22. (2008). High-dose single-fraction radiotherapy: exploiting a new biology?
  23. (2007). Hypoxia, gene expression, and metastasis.
  24. (2001). Improved quantification of angiogenesis in the rat aortic ring assay.
  25. (2005). Increased carotid wall thickening after radiotherapy on the neck.
  26. (2001). Induction of a senescence-like phenotype in bovine aortic endothelial cells by ionizing radiation.
  27. (2006). Inhibition of endothelial cell proliferation by Notch1 signaling is mediated by repressing MAPK and PI3K/Akt pathways and requires MAML1.
  28. (2006). Inhibition of p53 response in tumor stroma improves efficacy of anticancer treatment by increasing antiangiogenic effects of chemotherapy and radiotherapy in mice.
  29. (2007). Inhibition of TGF-beta with neutralizing antibodies prevents radiation-induced acceleration of metastatic cancer progression.
  30. (2010). Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice.
  31. (1998). Integration of endothelial cells in multicellular spheroids prevents apoptosis and induces differentiation.
  32. (2004). Integration of TGFbeta/Smad and Jagged1/Notch signalling in epithelial-to-mesenchymal transition.
  33. (2009). Ionizing radiation shifts the PAI-1/ID-1 balance and activates notch signaling in endothelial cells.
  34. (1992). Local control and patient survival.
  35. (1996). Long-term expression of transforming growth factor TGF beta 1 in mouse skin after localized beta-irradiation.
  36. (1992). Malathi A
  37. (2008). Matrix metalloproteinase-9 is required for tumor vasculogenesis but not for angiogenesis: role of bone marrow-derived myelomonocytic cells.
  38. (2009). Mobilization of circulating vascular progenitors in cancer patients receiving external beam radiation in response to tissue injury.
  39. (2007). Moustakas A
  40. (1993). Negative regulation of G1 in mammalian cells: inhibition of cyclin E-dependent kinase by TGF-beta.
  41. (2004). Notch activation induces endothelial cell cycle arrest and participates in contact inhibition: role of p21Cip1 repression.
  42. (2002). Oncogenic ras induces premature senescence in endothelial cells: role of p21(Cip1/Waf1).
  43. (1990). Ottinetti A
  44. (1994). p15INK4B is a potential effector of TGF-betainduced cell cycle arrest.
  45. (1987). Quantitation of erythroid differentiation in vitro using a sensitive colorimetric assay for hemoglobin.
  46. (2005). Radiation and the microenvironment - tumorigenesis and therapy.
  47. (1993). Radiation-induced transforming growth factor beta and subsequent extracellular matrix reorganization in murine mammary gland.
  48. (2007). Radiationinduced senescence-like phenotype in proliferating and plateau-phase vascular endothelial cells.
  49. (2005). Radiotherapy and wound healing.
  50. (1999). Regulation of p53 in response to DNA damage.
  51. (2007). Signaling by ALK5 mediates TGF-beta-induced ET-1 expression in endothelial cells: a role for migration and proliferation.
  52. (1995). Tables of equivalent dose in 2 Gy fractions: a simple application of the linear quadratic formula.
  53. (2005). TGF-beta inhibitors for the treatment of cancer.
  54. (2005). TGF-beta receptor function in the endothelium.
  55. (2006). TGFbeta1 induces vasculogenesis and inhibits angiogenic sprouting in an embryonic stem cell differentiation model: respective contribution of ALK1 and ALK5.
  56. (2000). The influence of the microenvironment on the malignant phenotype.
  57. (1999). The molecular and cellular basis of radiosensitivity: implications for understanding how normal tissues and tumors respond to therapeutic radiation.
  58. (2005). The pathology of ionizing radiation as defined by morphologic patterns.
  59. (2002). The sponge/Matrigel angiogenesis assay.
  60. (2005). The tumor bed effect: increased metastatic dissemination from hypoxia-induced upregulation of metastasis-promoting gene products.
  61. (1995). Transforming growth factor beta induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism.
  62. (1994). Transforming growth factor-beta activation in irradiated murine mammary gland.
  63. (2006). Transforming growth factor-beta in cancer and metastasis.
  64. (2005). Transforming growth factor-beta: biology and clinical relevance.
  65. (2008). Tumor angiogenesis.
  66. (2008). Tumor recovery by angiogenic switch from sprouting to intussusceptive angiogenesis after treatment with PTK787/ZK222584 or ionizing radiation.
  67. (2003). Tumor response to radiotherapy regulated by endothelial cell apoptosis.
  68. (2006). Validation of the 2-DeltaDeltaCt calculation as an alternate method of data analysis for quantitative PCR of BCRABL P210 transcripts.
  69. Yang LX (2008) Gamma-H2AX - a novel biomarker for DNA doublestrand breaks.